HRMY FY 2025 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$868M+21.5% YoY

Gross Profit

$670M77.2% margin

Operating Income

$208M24.0% margin

Net Income

$159M18.3% margin

EPS (Diluted)

$2.71

Cash Flow

Operating Cash Flow

$348M

Free Cash Flow

$348M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$401M

Stockholders' Equity

$870M

Cash & Equivalents

$753M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$868M	$715M	+21.5%
Gross Profit	$670M	$558M	+20.1%
Operating Income	$208M	$191M	+9.2%
Net Income	$159M	$145M	+9.1%